The research was carried out to measure the effectiveness of the polypill strategy compared to usual care in patients with myocardial infarction within the last 6 months. For this purpose, a parallel and randomized study was...
Most Recent Articles
2022 ESC Guidelines on Cardio-Oncology
Guidelines on cardio-oncology are the result of the immense work of the European Society of Cardiology (ESC), the European Society for Therapeutic Radiology and Oncology, the European Hematology Association, and the International...
ESC 2022: Artificial Intelligence Beats Out Sonographers for Echocardiogram Initial Assessment
Cardiologists presented during the 53rd Annual European Society of Cardiology Congress held online (26th to 29th August), Barcelona, Spain, that artificial intelligence (AI) through a deep learning model is suitable for...
Long-Term Evolocumab in Patients with Established ASCVD
In FOURIER, the use of evolocumab, which is a PCSK9 inhibitor and reduced the level of LDL-C, ultimately reducing the risk of cardiovascular disease. The parent FOURIER trial included 27564 patients with atherosclerosis...
Higher Artificial Sweetener Consumption Linked to CVD Risk
In Europe, data obtained from more than 100000 people provide awareness that consumption of artificial sweeteners is associated with cardiovascular disease. A group study in France showed that the risk of increased cardiovascular...